NovaResp Technologies
Incubation, Investment

NovaResp has developed a respiratory monitoring device and algorithm and is focused on making airway management self-learning and proactively adaptive to a patient’s needs.

The company’s lead product – cMAP – can help positive airway pressure (PAP) machines respond proactively through tailored pre-emptive therapy, resulting in a safer, more comfortable solution for patients suffering from sleep apnea.